Phase 1 Safety and Immunogenicity Evaluation of ADMVA, a Multigenic, Modified Vaccinia Ankara-HIV-1 B'/C Candidate Vaccine

Overview of attention for article published in PLOS ONE, January 2010

Altmetric Badge

Citations

dimensions_citation: 45 Dimensions

Readers on

mendeley: 35 Mendeley

Summary Dimensions citations

So far, Dimensions has found 45 publications that cite this research output.

45

The most recent citing publications are shown below. View all 45 publications that cite this research output on Dimensions.

Optimized Mucosal Modified Vaccinia Virus Ankara Prime/Soluble gp120 Boost HIV Vaccination Regimen Induces Antibody Responses Similar to Those of an Intramuscular Regimen.

Article in Journal of Virology (June 2019)

Optimized Mucosal MVA Prime/ Soluble gp120 Boost Vaccination Regimen Induces Similar Antibody Responses as an Intramuscular Regimen

Preprint in bioRxiv (March 2019)

Vaccination with Combination DNA and Virus-Like Particles Enhances Humoral and Cellular Immune Responses upon Boost with Recombinant Modified Vaccinia Virus Ankara Expressing Human Immunodeficiency Virus Envelope Proteins

Article in Vaccines (December 2017)